CX Institutional
AMPH icon

CX Institutional’s Amphastar Pharmaceuticals AMPH Stock Holding History

CX Institutional’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15K Sell
573
-686
-54% -$14.8K ﹤0.01% 1275
2026
Q2 		$25K Sell
1,259
-1,714
-58% -$34.6K ﹤0.01% 1118
2026
Q1 		$58K Sell
2,973
-61,150
-95% -$1.5M ﹤0.01% 948
2025
Q4 		$1.72M Buy
64,123
+807
+1% +$20.8K 0.05% 224
2025
Q3 		$1.69M Sell
63,316
-199,967
-76% -$5.16M 0.05% 226
2025
Q2 		$6.04M Buy
263,283
+181,136
+221% +$4.49M 0.21% 117
2025
Q1 		$2.38M Buy
+82,147
New +$2.62M 0.09% 180

Other funds holding AMPH

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

CX Institutional's AMPH Position: Q3 2026 in Review

CX Institutional reduced its Amphastar Pharmaceuticals (AMPH) stake by 54% in Q3 2026, selling an estimated $14.8K and leaving 573 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

CX Institutional first reported a position in AMPH in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.04M in Q2 2025. 11 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • CX Institutional held 573 shares of Amphastar Pharmaceuticals worth $15K as of Q3 2026.
  • CX Institutional sold 686 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $14.8K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1275 holding.
  • CX Institutional first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • CX Institutional's Amphastar Pharmaceuticals position peaked at $6.04M in Q2 2025.
  • 11 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.